Structures by: Shivananda K. N.
Total: 14
(<i>E</i>)-3-[3-(4-Bromophenyl)-1-phenyl-1<i>H</i>-pyrazol-4-yl]-1- (2,4-dichlorophenyl)prop-2-en-1-one
C24H15BrCl2N2O
Acta Crystallographica Section E (2011) 67, 11 o3104
a=11.4203(14)Å b=9.9357(13)Å c=19.656(3)Å
α=90.00° β=94.653(3)° γ=90.00°
4-(1,3-Diphenyl-4,5-dihydro-1<i>H</i>-pyrazol-5-yl)-1,3-diphenyl-1<i>H</i>- pyrazole
C30H24N4
Acta Crystallographica Section E (2011) 67, 11 o2822-o2823
a=10.7841(5)Å b=11.0582(6)Å c=21.4820(9)Å
α=90.00° β=113.359(2)° γ=90.00°
4-(Morpholin-4-yl)-3-(trifluoromethyl)benzonitrile
C12H11F3N2O
Acta Crystallographica Section E (2011) 67, 7 o1600
a=12.7003(12)Å b=6.8990(7)Å c=13.3484(13)Å
α=90.00° β=91.668(2)° γ=90.00°
Diethyl 2,6-dimethyl-4-(5-phenyl-1<i>H</i>-pyrazol-4-yl)- 1,4-dihydropyridine-3,5-dicarboxylate
C22H25N3O4
Acta Crystallographica Section E (2012) 68, 3 o892-o893
a=9.7700(4)Å b=8.6431(4)Å c=24.8878(9)Å
α=90.00° β=105.646(2)° γ=90.00°
(2<i>E</i>)-2-(4-Fluorobenzylidene)hydrazinecarboxamide
C8H8FN3O
Acta Crystallographica Section E (2011) 67, 11 o2885-o2886
a=16.522(2)Å b=4.4381(6)Å c=11.9457(15)Å
α=90.00° β=103.478(3)° γ=90.00°
(<i>E</i>)-1-(2,4-Dichlorophenyl)-3-(1,3-diphenyl-1<i>H</i>- pyrazol-4-yl)prop-2-en-1-one
C24H16Cl2N2O
Acta Crystallographica Section E (2011) 67, 11 o3102-o3103
a=9.6185(8)Å b=10.6596(9)Å c=11.8537(10)Å
α=67.377(2)° β=75.7770(10)° γ=69.934(2)°
2-(4-Fluorophenyl)-2-oxoethyl 3-(trifluoromethyl)benzoate
C16H10F4O3
Acta Crystallographica Section E (2011) 67, 11 o2836
a=14.7694(19)Å b=12.1602(16)Å c=8.0929(10)Å
α=90.00° β=95.886(2)° γ=90.00°
2-[(<i>E</i>)-4-Diethylamino-2-hydroxybenzylidene]hydrazinecarboxamide
C12H18N4O2
Acta Crystallographica Section E (2012) 68, 2 o380
a=8.794(2)Å b=12.532(3)Å c=14.292(5)Å
α=112.911(7)° β=96.033(7)° γ=107.296(5)°
<i>N</i>-(5-Bromopyridin-2-yl)acetamide
C7H7BrN2O
Acta Crystallographica Section E (2011) 67, 8 o2043
a=4.0014(3)Å b=8.7232(6)Å c=23.0626(18)Å
α=82.1270(10)° β=86.8970(10)° γ=85.9320(10)°
2-(4-Chlorophenyl)-2-oxoethyl 4-hydroxybenzoate
C15H11ClO4
Acta Crystallographica Section E (2011) 67, 10 o2682
a=5.5307(10)Å b=8.1324(15)Å c=14.857(2)Å
α=90.00° β=95.120(4)° γ=90.00°
Dimethyl 2,6-dimethyl-4-(3-phenyl-1<i>H</i>-pyrazol-4-yl)- 1,4-dihydropyridine-3,5-dicarboxylate
C20H21N3O4
Acta Crystallographica Section E (2012) 68, 4 o922-o923
a=13.9632(6)Å b=10.9908(5)Å c=11.8465(5)Å
α=90.00° β=90.00° γ=90.00°
4-[3-(Biphenyl-4-yl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazol-5-yl]-3-(4-\ methoxyphenyl)-1-phenyl-1<i>H</i>-pyrazole dioxane monosolvate
C37H30N4O,C4H8O2
Acta Crystallographica Section E (2012) 68, 4 o972-o973
a=11.1189(2)Å b=13.0541(2)Å c=13.0852(2)Å
α=117.3090(10)° β=90.4680(10)° γ=98.5580(10)°
Dimethyl 4-[3-(4-methoxyphenyl)-1-phenyl-1<i>H</i>-pyrazol-4-yl]- 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate dihydrate
C27H27N3O5,2(H2O)
Acta Crystallographica Section E (2012) 68, 7 o2210-o2211
a=14.1279(9)Å b=11.6313(7)Å c=15.3780(9)Å
α=90.00° β=93.3580(10)° γ=90.00°
Ethyl 4-({1-[2-(4-bromophenyl)-2-oxoethyl]-1<i>H</i>-1,2,3-triazol-4-yl}methoxy)-8-(trifluoromethyl)quinoline-3-carboxylate
C24H18BrF3N4O4
Acta Crystallographica Section E (2012) 68, 12 o3387-o3388
a=5.2809(2)Å b=24.5131(10)Å c=18.3517(7)Å
α=90.00° β=99.6430(10)° γ=90.00°